Corporate Profile
| Company Name |
Nipro Pharma Corporation |
|---|---|
| Capital |
8,669 million yen (as of May, 2023) |
| Representative |
Kenichi Nishida, Representative Director and President |
| Head Office |
3-26, Senriokashinmachi, Settsu City, Osaka, 566-8510, Japan |
| Established |
August 1, 1948 |
| Incorporated |
July 25, 1950 |
| Number of employees |
4,044 (as of March 2024) |
| Director & Auditor |
Kenichi Nishida, President Kazuto Hanazono, Managing Director Hideki Tomimatsu, Managing Director Satoshi Kawamura, Director Takahiro Oichi, Director Yasunobu Tamaki, Director Masato Moriguchi, Director Takashi Nakamichi, Director Hisanori Miyawaki, Director Naoki Okamoto, Director Terutoshi Maeda, Outside Director Yoshiko Tanaka, Outside Director Takehito Yogo, Auditor (as of June 19,2024) |
| Operating Officer |
Koki Iwama, Operating Officer Hidemoto Takeuchi, Operating Officer Susumu Kimura, Operating Officer Yasuo Nishida, Operating Officer Shohei Otani, Operating Officer Naoya Nishimura, Operating Officer Eiji Fukui, Operating Officer Kengo Yamada, Operating Officer (as of June 19,2024) |
| Main business |
Manufacturing, sales, importing and exporting of pharmaceutical products |
| Production Bases／ Analysis Center |
Odate, Ise, Kagamiishi, |
| Group Companies |
Nipro Corporation, |
| Subsidiary Company |
Nipro Pharma Vietnam Co.,Ltd., |
| Main Bank of Account |
Mizuho Bank,Ltd., Resona Bank,Limited, |
| A member of |
The Federation of Pharmaceutical Manufacturers' Associations of Japan |
